Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D020106 |
Acrylamide |
Acrylamide analog affects the activity of KCNQ2 protein | affects activity | 16904708
|
D020106 |
Acrylamide |
Acrylamide analog affects the activity of [KCNQ2 protein binds to KCNQ3 protein] | affects activity|affects binding | 16904708
|
D020106 |
Acrylamide |
Acrylamide analog results in increased activity of KCNQ2 protein | increases activity | 15603955 15357987 15139767
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of KCNQ2 mRNA | affects expression | 16483693
|
D016589 |
Astemizole |
Astemizole inhibits the reaction [Histamine results in decreased activity of [KCNQ2 protein co-treated with KCNQ3 protein co-treated with HRH1 protein]] | affects cotreatment|decreases activity|decreases reaction | 12147327
|
C055494 |
caffeic acid phenethyl ester |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of KCNQ2 mRNA | affects cotreatment|decreases expression | 20360939
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of KCNQ2 mRNA | affects cotreatment|decreases expression | 20360939
|
D005038 |
Ethylnitrosourea |
Ethylnitrosourea results in increased mutagenesis of KCNQ2 exon | increases mutagenesis | 16464983
|
D005472 |
Fluorouracil |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of KCNQ2 mRNA] | affects reaction|decreases expression | 15016801
|
D006632 |
Histamine |
Astemizole inhibits the reaction [Histamine results in decreased activity of [KCNQ2 protein co-treated with KCNQ3 protein co-treated with HRH1 protein]] | affects cotreatment|decreases activity|decreases reaction | 12147327
|
D006632 |
Histamine |
Histamine results in decreased activity of [KCNQ2 protein co-treated with KCNQ3 protein co-treated with HRH1 protein] | affects cotreatment|decreases activity | 12147327
|
C476437 |
N-(1-(3-morpholin-4-ylphenyl)ethyl)-3-phenylacrylamide |
N-(1-(3-morpholin-4-ylphenyl)ethyl)-3-phenylacrylamide affects the activity of KCNQ2 protein | affects activity | 16904708
|
C476437 |
N-(1-(3-morpholin-4-ylphenyl)ethyl)-3-phenylacrylamide |
N-(1-(3-morpholin-4-ylphenyl)ethyl)-3-phenylacrylamide affects the activity of [KCNQ2 protein binds to KCNQ3 protein] | affects activity|affects binding | 16904708
|
C476437 |
N-(1-(3-morpholin-4-ylphenyl)ethyl)-3-phenylacrylamide |
N-(1-(3-morpholin-4-ylphenyl)ethyl)-3-phenylacrylamide results in increased activity of KCNQ2 protein | increases activity | 15139767
|
C492891 |
N-(1-(4-cyclopropylmethyl-3,4-dihydro-2H-benzo(1,4)oxazin-6-yl)ethyl)-3-(2-fluorophenyl)acrylamide |
N-(1-(4-cyclopropylmethyl-3,4-dihydro-2H-benzo(1,4)oxazin-6-yl)ethyl)-3-(2-fluorophenyl)acrylamide results in increased activity of KCNQ2 protein | increases activity | 15050644
|
C477185 |
N-(1-(4-fluoro-3-morpholin-4-ylphenyl)ethyl)-3-(4-fluorophenyl)acrylamide |
N-(1-(4-fluoro-3-morpholin-4-ylphenyl)ethyl)-3-(4-fluorophenyl)acrylamide results in increased activity of KCNQ2 protein | increases activity | 12930139
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of KCNQ2 mRNA | increases expression | 17879257
|
D013749 |
Tetrachlorodibenzodioxin |
AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of KCNQ2 mRNA] | affects reaction|increases expression | 16891777
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of KCNQ2 mRNA | increases expression | 16891777
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.96 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.68 | 18287403 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
2.44 | 17638652 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
7.17 | 10737359 6695378 |
MESH:D000236 |
Adenoma |
|
Ethylnitrosourea |
7.17 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
10.45 | 18056438 17620307 16434500 19061943 17162532 19052882 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.45 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.83 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.04 | 17306315 16712894 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
8.94 | 15504547 17963324 16511603 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.94 | 11748828 |
MESH:D000799 |
Angioedema |
|
Astemizole |
5.80 | 2883202 |
MESH:D001249 |
Asthma |
|
Histamine |
3.92 | 16387687 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.12 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.92 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.81 | 15746008 |
MESH:D001927 |
Brain Diseases |
|
Ethylnitrosourea |
4.96 | 14991843 |
MESH:D001932 |
Brain Neoplasms |
|
Ethylnitrosourea |
4.37 | 16651633 16357521 16436596 18412241 15144691 |
MESH:D001943 |
Breast Neoplasms |
|
Acrylamide |
2.02 | 16253758 18183576 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.02 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
2.02 | 15136595 16595493 19217205 18608205 18357371 16557594 16110121 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.02 | 20435547 |
MESH:D001986 |
Bronchial Spasm |
|
Histamine |
5.95 | 18298128 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.80 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
8.40 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.40 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
4.71 | 19335982 21159647 18210153 20007298 17055752 16681979 3581430 18691550 17761372 18056438 20214788 16540662 17978847 16807293 17138121 11831363 16502159 16779866 16878318 18971187 16288022 10737359 16569478 16830150 20727157 19394651 19208518 18665156 18393292 19822196 17173139 20512989 19919837 18978308 16935385 19519916 19539802 17428255 19701751 20524982 18506893 20101231 20514400 20084675 18788625 17162532 3084413 16698587 19171122 19383236 19052882 19107877 16328049 18785209 10672840 20935162 19418558 20432363 18494052 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
4.71 | 18930000 17045692 17971768 16332177 17088986 16799960 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
4.71 | 17306315 15276417 16507464 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
3.05 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
4.83 | 16280240 17066447 16757204 18986760 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.83 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.41 | 16120746 18850075 18670907 |
MESH:D002418 |
Cattle Diseases |
|
Acrylamide |
5.58 | 12510666 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
11.67 | 21159647 17174075 2727394 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Ethylnitrosourea |
11.67 | 16003739 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
11.67 | 20056578 19524636 |
MESH:D016543 |
Central Nervous System Neoplasms |
|
Ethylnitrosourea |
6.12 | 17160924 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
9.57 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
9.57 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.13 | 16354765 8697196 12621046 15340226 15668235 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
2.24 | 16510598 17725105 15001691 17018589 18772588 17172411 17016597 17169374 17287894 16340194 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.00 | 18288408 18383874 18448328 16331619 16391804 20501625 14970324 17695437 17255274 18509181 17094418 16303861 17594712 17454858 18949393 16282729 17016601 17401013 15289873 15148649 16524972 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.13 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 20055451 15322242 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.91 | 16733453 |
MESH:D002658 |
Developmental Disabilities |
marker/mechanism |
|
| 20805988 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.28 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.28 | 17107852 |
MESH:D004244 |
Dizziness |
|
Astemizole |
6.60 | 3105558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
3.80 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.80 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.82 | 11462148 |
MESH:D004476 |
Ectodermal Dysplasia |
|
Ethylnitrosourea |
6.12 | 18357618 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.46 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.04 | 16714409 15322242 18230668 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.10 | 10568697 9294722 |
MESH:D004802 |
Eosinophilia |
|
Astemizole |
10.16 | 1355641 |
MESH:D004802 |
Eosinophilia |
|
Histamine |
10.16 | 12689652 |
MESH:D004827 |
Epilepsy |
marker/mechanism |
|
| 16464983 |
MESH:D020936 |
Epilepsy, Benign Neonatal |
marker/mechanism |
|
| |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.25 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
2.47 | 16337965 15173087 16481741 16785472 17638652 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.07 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
3.27 | 20387270 21071580 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.56 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.05 | 20067830 |
MESH:D005499 |
Folliculitis |
|
Astemizole |
6.05 | 1671328 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.80 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Ethylnitrosourea |
3.88 | 16436596 |
MESH:D005910 |
Glioma |
|
Ethylnitrosourea |
6.45 | 16651633 18412241 16357521 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
6.45 | 16145905 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.73 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
3.44 | 15102660 15162350 18337622 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.37 | 10048152 11294989 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.42 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.00 | 15340226 16120746 12621046 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.22 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.18 | 18606429 15340226 16959395 8697196 16354765 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.93 | 18850075 18670907 |
MESH:D007247 |
Infertility, Female |
|
Acrylamide |
5.29 | 11020651 |
MESH:D007248 |
Infertility, Male |
|
Acrylamide |
7.46 | 12507653 15749267 11020651 15355880 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
7.46 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
5.03 | 18785209 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.03 | 12878042 12200463 |
MESH:D007414 |
Intestinal Neoplasms |
|
caffeic acid phenethyl ester |
4.66 | 10783313 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.42 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
caffeic acid phenethyl ester |
6.61 | 15369732 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.61 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Ethylnitrosourea |
8.06 | 17379185 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
8.06 | 16985049 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
caffeic acid phenethyl ester |
4.04 | 16766008 |
MESH:D017513 |
Lichen Nitidus |
|
Astemizole |
6.60 | 2563723 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.87 | 19638242 18665156 18407596 20032147 18522880 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.12 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
10.95 | 19690152 15885732 19638242 2862719 20137499 2422723 12771043 10737359 19812893 20583210 19254457 19073162 19426721 20492335 19294768 19996281 18648771 19090486 12112319 18977376 21047994 19850985 21278145 20434301 18754104 21071580 19499222 19551842 20452335 19255062 20101389 9163691 15175105 21167192 18644402 20405173 19427195 20501860 16942905 20118626 19833225 18978307 19256749 19642983 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
10.95 | 15113037 16603448 17045692 18383874 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
10.95 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.95 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
5.93 | 18282651 3124819 19004024 19009564 17854601 18775883 2563599 18079962 18308698 18544905 17942915 16267830 16842330 19539802 19519916 18093689 18164116 19126423 18253720 9362446 17174075 21159647 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.93 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
Astemizole |
4.66 | 18472280 11989578 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.22 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
6.70 | 20970405 21163286 6695378 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Ethylnitrosourea |
6.70 | 6695378 16271038 17703301 16019985 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
6.70 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
6.70 | 17306315 15276417 16712894 17077188 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.70 | 11884234 19555203 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.91 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Ethylnitrosourea |
4.00 | 15790496 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Ethylnitrosourea |
5.15 | 15375218 |
MESH:D008288 |
Malaria |
|
Astemizole |
4.79 | 16816845 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylnitrosourea |
3.56 | 10767621 18041768 10838139 |
MESH:D008545 |
Melanoma |
|
Histamine |
3.95 | 17709802 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.95 | 16487513 19082730 |
MESH:D008579 |
Meningioma |
|
Ethylnitrosourea |
6.12 | 17943659 |
MESH:D008881 |
Migraine Disorders |
|
N-(1-(4-fluoro-3-morpholin-4-ylphenyl)ethyl)-3-(4-fluorophenyl)acrylamide |
6.31 | 12930139 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.69 | 18986760 16757204 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.08 | 12213967 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.59 | 3581430 9029167 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
5.31 | 18600527 18239605 16928823 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.31 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
Ethylnitrosourea |
9.73 | 16707424 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
9.73 | 20056578 |
MESH:D009410 |
Nerve Degeneration |
|
Acrylamide |
4.76 | 12387366 12387367 11264303 |
MESH:D009422 |
Nervous System Diseases |
marker/mechanism |
|
| 20805988 |
MESH:D009422 |
Nervous System Diseases |
|
Acrylamide |
5.06 | 12507653 12164553 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.31 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.19 | 12854658 |
MESH:D009442 |
Neurilemmoma |
|
Ethylnitrosourea |
5.53 | 16003739 17160924 16651423 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.41 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.25 | 20387270 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.49 | 16436463 |
MESH:D009759 |
Nystagmus, Pathologic |
|
Astemizole |
6.60 | 6135121 |
MESH:D009837 |
Oligodendroglioma |
|
Ethylnitrosourea |
6.12 | 17160924 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
2.46 | 17306315 15276417 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
5.41 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
5.41 | 16500647 16929163 19003803 15113037 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.38 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Acrylamide |
5.20 | 11510240 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.65 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.62 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.31 | 11118676 11399792 11896295 11222880 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
3.33 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.33 | 16039940 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.08 | 16160472 15538739 18286688 18722050 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.93 | 18990726 |
MESH:D012220 |
Rhinitis |
|
Histamine |
5.05 | 12689652 |
MESH:D012221 |
Rhinitis, Allergic, Perennial |
|
Astemizole |
5.56 | 10822083 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
5.71 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.71 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.86 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.51 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.51 | 19084572 18396642 17172411 17522103 16951190 16424979 15786421 18567086 17498489 19015929 |
MESH:D013733 |
Testicular Diseases |
|
Acrylamide |
5.35 | 15864552 |
MESH:D013953 |
Thymus Neoplasms |
|
Ethylnitrosourea |
5.28 | 15790496 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.04 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
3.04 | 7505956 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
4.06 | 16280240 |
MESH:D016171 |
Torsades de Pointes |
|
Astemizole |
5.32 | 9583453 8256756 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
2.53 | 16712894 16452187 17306315 11723127 |
MESH:D014581 |
Urticaria |
|
Astemizole |
10.09 | 2147912 3080510 3097109 2885854 3134034 2568189 2568013 2859714 2565098 1683191 1976298 2883202 |
MESH:D014581 |
Urticaria |
|
Histamine |
10.09 | 18298128 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
9.74 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
9.74 | 11813266 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.54 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.73 | 12125929 |
MESH:D014717 |
Vertigo |
|
Astemizole |
6.60 | 3105558 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.38 | 15886252 |